XXXVIII
Congreso de la Sociedad Española de Inmunología Clínica, Alergología y Asma Pediátrica
99
Anticholinergic drugs for wheeze
in children under the age of two
years. Cochrane Database Sys Rev.
2005;(3):CD001279.
15.
Vuillermin P, South M, Robertson
C. Parent-initiated oral corticoster-
oid therapy for intermittent wheez-
ing illnesses in children. Cochrane
Database Syst Rev 2003; Issue 1:
CD005311
16.
Saglani S, Malmstron K, Pelkonen
AS, Malmberg LP, Lindahl H, Ka-
josaari M, Turpeinen M, Ro-
gers AV, Payne DN, Bush A. Airway
remodeling and inflammation in
symptomatic infants with reversi-
ble airflow obstruction. Am J Respir
Crit Car Med 2005; 171: 722 – 727
17.
Saglani S, Payne DN, Zhu J, Wang
Z, Nicholson AG, Bush A, Jeffery PK.
Early detection of airway wall remo-
deling and eosinophilic inflamma-
tion in preschool wheezers Am J
Respir Crit Car Med 2007, 176 : 858-
864
18.
Castro-Rodriguez JA, Holberg CJ,
Wright AL, Martinez FD. A clinical
index to define risk of asthma in
young children with recurrent whe-
ezing. Am J Respir Crit Care Med
2000; 162: 1403-1406.
19.
GuilbertTW, MorganWJ, Zeiger RS,
Bacharier LB, Boehmer SJ, Krawiec
et al. Atopic characteristics of chil-
dren with recurrent wheezing at
high risk for the development of
childhood asthma. J Allergy Clin
Immunol 2004; 114: 1282-1287
20.
Bisgaard H, Munck SL, Nielsen JP,
PetersenW, Ohlsson SV. Inhaled bu-
desonide for treatment of recurrent
wheezing in early childhood. Lancet
1990; 336: 649-651.
21.
Connett GJ,Warde C,Wooler E, Len-
neyW. Use of budesonide in severe
asthmatics aged 1-3 years. Arch Dis
Child 1993; 69: 351-355
6.
Gibson PG, Powell H. Written action
plans for asthma: an evidence-based
review of the key components.Tho-
rax 2004;59:94-99.
7.
Pedersen S. Delivery systems in
children. In Barnes PJ, Grunstein
MM,
Leff AR, Woolcock AJ (ed) Asthma II
1ª Ed Philadelphia: Lippincot-Raven;
1997.
8.
Cates CC, Bara A, Crilly JA, Rowe
BH. Holding chambers versus nebu-
lisers for beta-agonist treatment of
acute asthma. Cochrane Database
Syst Rev. 2003;(3):CD000052.
9.
Lazarus SC, Chinchilli VM,Rollings
NJ, Boushey HA,Cherniack R, Craig
TJ,et al. Smoking affects response
to inhaled corticosteroids or leukot-
riene receptor antagonists in asth-
ma. Am J Respir Crist Care Med.
2007;175:783-90.
10.
Illi S, Von Mutius E, Lau S, Nigge-
mann B, Gruber C, Whan U. Peren-
nial allergen sensitisation early in
life and chronic asthma in children
: a birth cohort study: Lancet 2006;
368 : 763 - 770
11.
Chavasse R, Seddon P, Bara A,
MckeanM. Short acting beta ago-
nists for recurrent wheeze in chil-
dren under 2 years of age. Cochrane
Database Syst Rev. 2002
12.
Skoner DP, Greos LS, Kim KT, Roach
JM, Parsey M, Baumgartner RA.
Evaluation of the safety and efficacy
of levaterol in 2-5 –year-old patients
with asthma.
Pediatr Pulmonol
2005
; 40: 477-486
13.
Cates CC, Bara A, Crilly JA, Rowe
BH. Holding chambers versus nebu-
lisers for beta-agonist treatment of
acute asthma. Cochrane Database
Syst Rev. 2003;(3):CD000052.
14.
Everard ML, Bara A, Kurian M, El-
liott TM, Ducharme F, Mayowe V.
